Skip to main content

Kaleido Biosciences, Inc.

KLDODelisted Apr 18, 2022
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001751299

Kaleido Biosciences, Inc. was delisted on Apr 18, 2022; its insiders filed their last Form 4 on Mar 2, 2022; 63 institutions reported holding it in 13F filings for Q1 2022, worth $55.1M in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding Kaleido Biosciences, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of KLDO: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders71710
Shares34.7M34.7M+63.8K (+0.2%)
Value$257.8M$189.6M−$68.2M (−26.5%)

New holders (10)

Institutions that held Kaleido Biosciences, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to KLDO in Q3 2021
InstitutionSharesValue% of portfolio
Ikarian Capital, LLC100,000$546.0K0.13%
State Board of Administration of Florida Retirement System34,018$186.0K0.00%
Renaissance Technologies LLC29,800$163.0K0.00%
Dimensional Fund Advisors LP10,484$57.0K0.00%
Boothbay Fund Management, LLC10,108$55.0K0.00%
Blackstone Group Inc.8,596$47.0K0.00%
Close Asset Management Ltd7,900$43.0K0.00%
Koshinski Asset Management, Inc.400$2.18K0.00%
TSFG, LLC100$1.00K0.00%
Ellevest, Inc.13$00.00%

Sold out (10)

Institutions that held Kaleido Biosciences, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of KLDO in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
First Trust Advisors LP55,056$410.0K
Two Sigma Advisers, LP46,000$342.0K
Susquehanna International Group, LLP22,895$170.0K
Exane Derivatives21,333$156.6K
Price T Rowe Associates Inc19,356$144.0K
D. E. Shaw & Co., Inc.10,483$78.0K
Endurance Wealth Management, Inc.1,000$5.00K
UBS Group AG500$4.00K
Cutler Group LP400$2.00K
Advisory Services Network, LLC90$1.00K